Literature DB >> 2943848

Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.

J V Anderson, A E Raine, A Proudler, S R Bloom.   

Abstract

Twenty patients with chronic renal failure were studied before and after haemodialysis. Plasma atrial natriuretic peptide (ANP) concentrations were markedly elevated (P less than 0.01) before dialysis in comparison with healthy control subjects. After haemodialysis the plasma ANP concentration was lower in 19 patients (P less than 0.01) but remained above the normal range in all but three cases. Systolic and diastolic blood pressure and body weight fell during dialysis but none of these changes correlated with the reduction of the plasma ANP concentration. Chromatographic analysis of plasma extracts indicated that alpha-ANP is the predominant circulating molecular form. The increase in concentration of ANP in plasma between dialyses, at a time when many patients are susceptible to sodium and water overload, and its return towards normal after dialysis supports the putative role of ANP as a circulating factor released in response to sodium and water accumulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943848     DOI: 10.1677/joe.0.1100193

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

1.  Atrial natriuretic peptide and water and electrolyte transport in the human jejunum.

Authors:  J Brunner; R Lübcke; G O Barbezat; T G Yandle; E A Espiner
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

2.  Atrial natriuretic peptide concentrations in pre-eclampsia.

Authors:  J Anderson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

3.  The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.

Authors:  J V Anderson; P W Woodruff; S R Bloom
Journal:  Br Heart J       Date:  1988-02

4.  Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency.

Authors:  L Meleagros; J S Gibbs; M A Ghatei; S R Bloom
Journal:  Br Heart J       Date:  1988-07

Review 5.  Effects of exercise on atrial natriuretic factor. Release mechanisms and implications for fluid homeostasis.

Authors:  B J Freund; C E Wade; J R Claybaugh
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

6.  The action of atriopeptin III on renal function in two models of chronic renal failure in the rat.

Authors:  E J Johns; B Rutkowski
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

7.  The hormonal responses to repetitive brief maximal exercise in humans.

Authors:  S Brooks; M E Nevill; L Meleagros; H K Lakomy; G M Hall; S R Bloom; C Williams
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

8.  Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases.

Authors:  M Yasuda; D Yasuda; K Tomooka; M Nobunaga
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 9.  Preservation of residual kidney function in hemodialysis patients: reviving an old concept.

Authors:  Anna T Mathew; Steven Fishbane; Yoshitsugu Obi; Kamyar Kalantar-Zadeh
Journal:  Kidney Int       Date:  2016-05-12       Impact factor: 10.612

10.  Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.

Authors:  P A Phillips; J Sasadeus; G P Hodsman; J Horowitz; A Saltups; C I Johnston
Journal:  Br Heart J       Date:  1989-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.